The Most Common Cause of Hemolytic Disease of the Newborn
D. ABO incompatibility is the most common cause of hemolytic disease of the newborn.
While anti-D (Rh incompatibility) historically dominated as the leading cause of HDFN, the widespread implementation of Rh immune globulin prophylaxis has dramatically shifted the epidemiologic landscape. ABO incompatibility now accounts for the majority of HDFN cases 1, 2.
Understanding the Current Epidemiology
Why ABO Incompatibility Predominates
Recent clinical data demonstrates that ABO incompatibility represents 39.2% of all HDFN cases, making it the single most prevalent etiology 2. In a comprehensive 5-year review of 275 newborns diagnosed with HDFN, the overwhelming majority involved group O mothers (259 cases), with the O/A incompatibility pattern accounting for 54.9% of cases, followed by O/B at 39.3% 1.
The most recent guidelines acknowledge that anti-D is responsible for most severe cases of HDFN requiring intensive intervention 3, but this reflects disease severity rather than overall incidence. The critical distinction is that while Rh disease causes more severe hemolysis when it occurs, ABO incompatibility affects far more pregnancies overall.
The Impact of Rh Prophylaxis
The introduction of routine antenatal anti-D prophylaxis (RAADP) in the third trimester has reduced D alloimmunization to approximately 1 in 1000 women 3. This public health success has unmasked ABO incompatibility as the predominant cause by sheer numbers, though Rh disease remains more clinically severe when prophylaxis fails.
Clinical Characteristics That Matter
ABO Incompatibility Patterns
- Most common scenario: Group O mother with group A or B infant
- Key feature: Often presents with milder disease than Rh incompatibility
- Diagnostic challenge: Direct antiglobulin test (DAT) is positive in only 14.9% of ABO-incompatible cases 2
- Critical pitfall: Negative DAT does not exclude ABO HDFN—elution tests reveal antibodies in DAT-negative neonates 2
Rh Incompatibility Characteristics
- Severity: Causes more severe anemia and hydrops when it occurs
- DAT sensitivity: 100% positive in confirmed Rh HDFN cases 2
- Antibody patterns: Anti-D most common, but anti-C, anti-c, anti-E, and anti-e also cause disease 3
- Risk factors: Prior sensitizing events (previous pregnancy, trauma, incompatible transfusion)
Why the Other Options Are Incorrect
E. coli sepsis causes hemolysis through direct bacterial toxins and disseminated intravascular coagulation, not through maternal alloantibodies—this is an entirely different pathophysiologic mechanism and not classified as HDFN.
Biliary atresia presents with conjugated hyperbilirubinemia and cholestasis, not the unconjugated hyperbilirubinemia characteristic of hemolytic disease. While rare cases of HDFN can develop secondary cholestasis 4, biliary atresia is a structural obstruction, not a hemolytic process.
Management Implications
For ABO Incompatibility
- Treatment: 94.1% managed with phototherapy alone 2
- Exchange transfusion rate: Lower than Rh disease (5.9% in one series) 2
- Blood selection: Use group O red cells compatible with maternal plasma for exchange transfusion 1
For Rh Incompatibility
- Monitoring: Middle cerebral artery peak systolic velocity Doppler for fetal anemia detection 5
- Intervention: Intrauterine transfusion for severe cases, continued until 35 weeks gestation 5
- Delivery timing: Between 37+0 and 38+6 weeks 5
The Bottom Line
Answer: D. ABO incompatibility is definitively the most common cause of hemolytic disease of the newborn in current practice, accounting for approximately 40% of all cases 2. The success of Rh prophylaxis programs has relegated Rh incompatibility to a less frequent but more severe cause. E. coli sepsis and biliary atresia are not forms of HDFN and represent entirely different disease processes.